Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03414450
Title Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors D3 (Drug Discovery and Development), A*STAR Research Entities

chronic myeloid leukemia

acute lymphoblastic leukemia


Dasatinib + ETC-1907206

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.